602 related articles for article (PubMed ID: 7688628)
1. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
[TBL] [Abstract][Full Text] [Related]
2. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
[TBL] [Abstract][Full Text] [Related]
3. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favorable clinical outcome.
Kaplan LD; Shiramizu B; Herndier B; Hahn J; Meeker TC; Ng V; Volberding PA; McGrath MS
Blood; 1995 Apr; 85(7):1727-35. PubMed ID: 7535586
[TBL] [Abstract][Full Text] [Related]
4. MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Sertoli MR; Santini G; Chisesi T; Congiu AM; Rubagotti A; Contu A; Salvagno L; Coser P; Porcellini A; Vespignani M
J Clin Oncol; 1994 Jul; 12(7):1366-74. PubMed ID: 7517442
[TBL] [Abstract][Full Text] [Related]
5. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
6. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
Perri RT; Allen JI; Oken MM; Limas C; Kay NE
Med Pediatr Oncol; 1985; 13(3):122-5. PubMed ID: 3838792
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, epirubicin and etoposide (IEV) therapy in relapsed and refractory high-grade non-Hodgkin's lymphoma and Hodgkin's disease.
Zinzani PL; Barbieri E; Visani G; Gherlinzoni F; Perini F; Neri S; Bendandi M; Ammendolia I; Salvucci M; Babini L
Haematologica; 1994; 79(6):508-12. PubMed ID: 7534744
[TBL] [Abstract][Full Text] [Related]
9. HIV-related Hodgkin's disease. Report of nine cases.
Novati S; Malfitano A; Sacchi P; Patruno SF; Tornari PM; Rondanelli EG
Haematologica; 1993; 78(1):34-7. PubMed ID: 7684010
[TBL] [Abstract][Full Text] [Related]
10. Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
Bairey O; Gabbay U; Blickstein D; Stark P; Prokocimer M; Epstein O; Shaklai M; Lahav J
Hematol Oncol; 1997 Aug; 15(3):121-7. PubMed ID: 9600111
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Lévy R; Colonna P; Tourani JM; Gastaut JA; Brice P; Raphaël M; Taillan B; Andrieu JM
Leuk Lymphoma; 1995 Feb; 16(5-6):451-6. PubMed ID: 7540459
[TBL] [Abstract][Full Text] [Related]
12. Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Kirchner EM; Ebsen M; Kirchner J; Theegarten D; Voigtmann R
Ann Oncol; 2001 Aug; 12(8):1169-71. PubMed ID: 11583202
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Tirelli U; Errante D; Dolcetti R; Gloghini A; Serraino D; Vaccher E; Franceschi S; Boiocchi M; Carbone A
J Clin Oncol; 1995 Jul; 13(7):1758-67. PubMed ID: 7541452
[TBL] [Abstract][Full Text] [Related]
14. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
[TBL] [Abstract][Full Text] [Related]
16. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
[TBL] [Abstract][Full Text] [Related]
17. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
18. Drug-related pulmonary toxicity in non-Hodgkin's lymphoma. Comparative results with three different treatment regimens.
Shapiro CL; Yeap BY; Godleski J; Jochelson MS; Shipp MA; Skarin AT; Canellos GP
Cancer; 1991 Aug; 68(4):699-705. PubMed ID: 1713121
[TBL] [Abstract][Full Text] [Related]
19. EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Somers R; Carde P; Thomas J; Tirelli U; Keuning JJ; Bron D; Delmer A; de Bock R; De Wolf-Peeters C; Keunig JJ
Ann Oncol; 1994; 5 Suppl 2():85-9. PubMed ID: 7515651
[TBL] [Abstract][Full Text] [Related]
20. Treatment of AIDS-related non-Hodgkin's lymphoma with a twelve week chemotherapy program.
Sawka CA; Shepherd FA; Brandwein J; Burkes RL; Sutton DM; Warner E
Leuk Lymphoma; 1992 Oct; 8(3):213-20. PubMed ID: 1283356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]